What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis - Report - MDSpire
Advertisement
What are the beneficial treatment strategies in maintaining T lymphocyte subsets after cancer surgery? A systematic review and network meta-analysis
Clinical Report: Evaluating Effective Approaches for Preserving T Lymphocyte Subsets Post-Cancer Surgery
Overview
This systematic review and network meta-analysis evaluated various treatment strategies to maintain T lymphocyte subsets in patients undergoing cancer surgery.
Background
Perioperative alterations in T lymphocyte subsets can significantly influence tumor recurrence and recovery after surgery. Understanding how different treatment modalities affect these immune parameters is essential for optimizing outcomes in cancer surgery. This study aims to fill the gap in comparative effectiveness research regarding immunomodulatory strategies.
Data Highlights
Intervention
Effect on CD4+ Counts (SMD)
95% CI
IEN + NACT
12.33
7.44-17.04
TD
-
-
ERAS
-
-
TEAS
-
-
DEX
-
-
Key Findings
82 randomized controlled trials were included in the analysis.
IEN + NACT showed the greatest improvement in CD4+ counts.
Other effective strategies included targeted therapy, ERAS protocol, TEAS, and DEX analgesia.
The safety analysis indicated acceptable risks associated with the top-ranking interventions.
Maintaining T lymphocyte homeostasis is crucial for postoperative immune function.
Clinical Implications
The findings indicate that a multimodal perioperative management plan incorporating IEN + NACT, ERAS, TD, TEAS, and DEX may enhance immune function in cancer surgery patients.
Conclusion
The study highlights the importance of a comprehensive strategy to maintain T lymphocyte subsets in cancer surgery patients.
